Skip to main content

Anaptysbio, Inc

ANAB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001370053

No open-market purchases or sales by Anaptysbio, Inc insiders were filed in the last 90 days; 213 institutions reported holding it in 13F filings for Q2 2026, worth $2.05B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Anaptysbio, Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Anaptysbio, Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Anaptysbio, Inc
NameTitleLast reported holdingLast filingFilings, past year
Orwin John ADirector17,995Sep 17, 20264
Lizzul Paul F.Chief Medical Officer42,088Aug 7, 20265
Faga DanielPresident, CEO495,965Aug 7, 20266
Renton HollingsDirector10,995Jun 17, 20263
Schmid John P.Director37,652Jun 17, 20265
Hughes OwenDirector–May 13, 20261
Murphy Christopher M.Chief Financial Officer–May 13, 20261
Gray SusannahDirector–Apr 29, 20261
Loumeau Eric JCHIEF LEGAL OFFICER12,835Feb 13, 20267
Marquet MagdaDirector9,930Jan 16, 20262
Mulroy DennisCHIEF FINANCIAL OFFICER21,852Jan 9, 20265
Fenton Dennis MDirector4,965Jan 8, 20261
Jain RitaDirector11,864Jan 8, 20261
Ware J. AnthonyDirector9,630Jan 8, 20262
Nodelman OlegDirector, 10% Owner7,880,094IndirectJan 2, 20250
EcoR1 Capital, LLCDirector, 10% Owner7,880,094IndirectJan 2, 20250
Topper James NDirector, 10% Owner–Jan 10, 20230
Hamill LauraDirector–Jan 10, 20230
Suria HamzaPresident, CEO68,600Feb 14, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Apr 1, 2026 (view filing)Mar 302 daysSchmid John P.DirectorSSale−20.6K$56.11−$1.16M−39.5%31.6K after3 lots
Mar 27, 2026 (view filing)Mar 27Same dayFaga DanielPresident, CEOSSale−17.7K$61.61−$1.09M−3.4%496.0K after10 lots
Feb 13, 2026 (view filing)Feb 112 daysLoumeau Eric JCHIEF LEGAL OFFICERSSale−10.0K$54.00−$540.0K−43.8%12.8K after10b5-1
Jan 16, 2026 (view filing)Jan 151 dayMarquet MagdaDirectorSSale−11.0K$48.23−$530.6K−52.6%9.93K after2 lots
Jan 9, 2026 (view filing)Jan 81 dayLizzul Paul F.Chief Medical OfficerSSale−3.65K$44.71−$163.2K−8.0%42.1K after
Jan 9, 2026 (view filing)Jan 81 dayFaga DanielPresident, CEOSSale−14.3K$44.71−$638.5K−2.9%479.3K after
Jan 9, 2026 (view filing)Jan 81 dayMulroy DennisCHIEF FINANCIAL OFFICERSSale−2.52K$44.71−$112.4K−10.3%21.9K after
Jan 9, 2026 (view filing)Jan 81 dayLoumeau Eric JCHIEF LEGAL OFFICERSSale−2.21K$44.71−$98.8K−14.7%12.8K after
Jan 8, 2026 (view filing)Jan 71 dayLizzul Paul F.Chief Medical OfficerSSale−2.23K$45.11−$100.8K−5.7%37.2K after
Jan 8, 2026 (view filing)Jan 71 dayFaga DanielPresident, CEOSSale−9.20K$45.11−$415.1K−1.9%466.8K after
Jan 8, 2026 (view filing)Jan 71 dayMulroy DennisCHIEF FINANCIAL OFFICERSSale−1.91K$45.11−$86.1K−9.7%17.7K after
Jan 8, 2026 (view filing)Jan 71 dayLoumeau Eric JCHIEF LEGAL OFFICERSSale−9.64K$45.56−$439.2K−51.3%9.16K after4 lots
Jan 6, 2026 (view filing)Jan 51 dayLizzul Paul F.Chief Medical OfficerSSale−4.22K$43.26−$182.5K−11.2%33.3K after
Jan 6, 2026 (view filing)Jan 51 dayFaga DanielPresident, CEOSSale−15.3K$43.26−$662.3K−3.2%458.1K after
Jan 6, 2026 (view filing)Jan 51 dayMulroy DennisCHIEF FINANCIAL OFFICERSSale−3.36K$43.26−$145.5K−19.0%14.3K after
Jan 6, 2026 (view filing)Jan 51 dayLoumeau Eric JCHIEF LEGAL OFFICERSSale−2.98K$43.26−$129.0K−18.4%13.3K after
Dec 23, 2025 (view filing)Dec 23Same dayWare J. AnthonyDirectorSSale−3.90K$49.58−$193.4K−28.8%9.63K after
Dec 23, 2025 (view filing)Dec 221 dayLizzul Paul F.Chief Medical OfficerSSale−1.50K$50.00−$75.0K−5.3%27.0K after10b5-1
Dec 23, 2025 (view filing)Dec 221 dayMulroy DennisCHIEF FINANCIAL OFFICERSSale−10.0K$50.00−$500.0K−51.5%9.40K after10b5-1
Dec 23, 2025 (view filing)Dec 221 dayLoumeau Eric JCHIEF LEGAL OFFICERSSale−10.0K$51.00−$510.0K−52.8%8.95K after10b5-1
Dec 18, 2025 (view filing)Dec 162 daysMulroy DennisCHIEF FINANCIAL OFFICERSSale−15.7K$44.86−$705.4K−62.6%9.40K after2 lots10b5-1
Dec 18, 2025 (view filing)Dec 16-182 daysLoumeau Eric JCHIEF LEGAL OFFICERSSale−22.6K$45.38−$1.03M−71.7%8.95K after4 lots10b5-1
Oct 1, 2025 (view filing)Sep 301 dayLoumeau Eric JCHIEF LEGAL OFFICERSSale−8.24K$29.00−$239.0K−47.6%9.09K after10b5-1
Aug 12, 2025 (view filing)Aug 84 daysRenton HollingsDirectorSSale−10.2K$19.62−$200.7K−67.3%4.96K after2 lots10b5-1
Jul 3, 2025 (view filing)Jul 21 dayRenton HollingsDirectorSSale−20.9K$23.57−$493.1K−80.8%4.96K after2 lots10b5-1
Jun 20, 2025 (view filing)Jun 182 daysFenton Dennis MDirectorSSale−3.02K$23.97−$72.3K−37.8%4.96K after10b5-1
Jun 20, 2025 (view filing)Jun 182 daysRenton HollingsDirectorSSale−3.02K$23.97−$72.3K−37.8%4.96K after10b5-1
Jan 2, 2025 (view filing)6:17 PM ETDec 30, 2024-Jan 2, 20253 daysNodelman Oleg and 1 otherDirector, 10% OwnerPPurchase+85.1K$12.92+$1.10M+1.1%7.88M after3 lots
Dec 3, 2024 (view filing)Nov 294 daysRenton HollingsDirectorSSale−10.0K$25.00−$250.0K−83.7%1.95K after10b5-1
Sep 24, 2024 (view filing)Sep 231 dayLizzul Paul F.Chief Medical OfficerSSale−1.50K$38.67−$58.0K−8.9%15.4K after10b5-1
Sep 17, 2024 (view filing)Sep 16-171 dayLoumeau Eric JCHIEF LEGAL OFFICERSSale−12.5K$39.40−$492.5K−79.4%3.24K after3 lots10b5-1
Sep 17, 2024 (view filing)Sep 161 dayLizzul Paul F.Chief Medical OfficerSSale−2.22K$38.93−$86.4K−12.6%15.4K after10b5-1
Sep 17, 2024 (view filing)Sep 161 dayMulroy DennisCHIEF FINANCIAL OFFICERSSale−12.2K$39.91−$487.7K−72.0%4.74K after2 lots10b5-1
Aug 16, 2024 (view filing)Aug 142 daysLizzul Paul F.Chief Medical OfficerSSale−2.00K$40.00−$80.0K−14.7%11.6K after10b5-1
Aug 16, 2024 (view filing)Aug 142 daysEcoR1 Capital, LLC10% OwnerPPurchase+274.0K$36.50+$10.0M+3.6%7.79M after
Jul 19, 2024 (view filing)Jul 181 dayLizzul Paul F.Chief Medical OfficerSSale−1.50K$35.00−$52.5K−11.4%11.6K after10b5-1
Jul 17, 2024 (view filing)Jul 152 daysRenton HollingsDirectorSSale−10.0K$30.64−$306.4K−83.7%1.95K after2 lots10b5-1
Jun 24, 2024 (view filing)Jun 213 daysFenton Dennis MDirectorSSale−1.95K$23.17−$45.2K−50.0%1.95K after10b5-1
Jun 18, 2024 (view filing)Jun 18Same dayRenton HollingsDirectorSSale−1.95K$23.16−$45.2K−50.0%1.95K after
May 24, 2024 (view filing)May 222 daysMulroy DennisCHIEF FINANCIAL OFFICERSSale−1.50K$23.72−$35.6K−60.9%964 after10b5-1
Mar 26, 2024 (view filing)Mar 22-254 daysFaga DanielCEOSSale−148.9K$22.75−$3.39M−16.6%749.1K after2 lots
Feb 21, 2024 (view filing)Feb 165 daysLoumeau Eric JCHIEF LEGAL OFFICERSSale−5.00K$25.00−$125.0K−60.7%3.24K after10b5-1
Feb 1, 2024 (view filing)Jan 302 daysMulroy DennisCHIEF FINANCIAL OFFICERSSale−3.06K$23.63−$72.4K−76.1%964 after
Jan 9, 2024 (view filing)Jan 81 dayLizzul Paul F.Chief Medical OfficerSSale−2.55K$21.81−$55.7K−20.2%10.1K after
Jan 9, 2024 (view filing)Jan 81 dayLoumeau Eric JChief Legal OfficerSSale−2.31K$21.81−$50.3K−41.6%3.24K after
Jan 9, 2024 (view filing)Jan 81 dayMulroy DennisChief Financial OfficerSSale−2.18K$21.81−$47.5K−35.1%4.03K after
Jan 9, 2024 (view filing)Jan 81 dayFaga DanielCEOSSale−6.87K$21.81−$149.7K−0.8%898.0K after
Nov 27, 2023 (view filing)Nov 225 daysLoumeau Eric JChief Legal OfficerSSale−882$14.19−$12.5K−100.0%0 after
Sep 18, 2023 (view filing)Sep 144 daysLizzul Paul F.Chief Medical OfficerSSale−2.10K$19.48−$41.0K−24.4%6.53K after
Sep 18, 2023 (view filing)Sep 14-184 daysLoumeau Eric JChief Legal OfficerSSale−6.00K$19.38−$116.3K−87.2%882 after2 lots